Latest News

Uncombable hair syndrome: One gene, variants responsible for many cases


 

FROM JAMA DERMATOLOGY

Research leads to possible treatment pathways

Jeff Donovan, MD, FRCPC, FAAD, a dermatologist and medical director of the Donovan Hair Clinic in Whistler, British Columbia, described these findings as fundamental to understanding UHS and creating pathways to possible treatments.

The study “identifies more about the genetic basis of this challenging condition,” said Dr. Donovan, who is also clinical instructor in the department of dermatology at the University of British Columbia, Vancouver, and president of the Canadian Hair Loss Foundation. “We really need this type of information in order to have any sort of clue in terms of how to treat it,” he told this news organization.

“In the hair loss world, it’s pretty clear that if you can understand the genetic basis of things, or the basic science of a condition, whether it’s the basic genetics or the basic immunology, you give yourself the best chance to develop good treatments,” said Dr. Donovan.

The article provides advanced genetic information of the condition, such that geneticists can test for at least three markers if they are suspecting UHS, Dr. Donovan observed.

Condition can lead to bullying

Dr. Donovan also commented that UHS can have a detrimental impact on children with regard to socializing with their peers. “Having hair that sticks out and is very full like this is challenging because kids do get teased,” he said.

“It is often the parents who are the most affected” when a child aged 2-5 years has a hair condition such as UHS. But at age 5-9, “children are developing self-identity and an understanding of various aspects of self-esteem and what they look like and what others look like. And that’s where the teasing really starts. And that’s where it does become troublesome.”

Dr. Betz and Dr. Donovan have disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

European committee recommends approval of baricitinib for severe alopecia areata
MDedge Family Medicine
FDA OKs first systemic treatment for alopecia areata
MDedge Family Medicine
Hair disorder treatments are evolving
MDedge Family Medicine
Baricitinib’s approval for alopecia areata: Considerations for starting patients on treatment
MDedge Family Medicine
Compulsivity contributes to poor outcomes in body-focused repetitive behaviors
MDedge Family Medicine
Skin-picking, hair-pulling disorders: Diagnostic criteria, prevalence, and treatment
MDedge Family Medicine
Low-level light therapy cap shows subtle effects on CCCA
MDedge Family Medicine
Sexual dysfunction, hair loss linked with long COVID
MDedge Family Medicine
Review cautions against influencer-promoted hair-growth remedies
MDedge Family Medicine
Expert shares tips on hair disorders and photoprotection for patients of color
MDedge Family Medicine